These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 21049301)
1. Activation of sulfonate ester based matrix metalloproteinase proinhibitors by hydrogen peroxide. Daniel KB; Major Jourden JL; Negoescu KE; Cohen SM J Biol Inorg Chem; 2011 Feb; 16(2):313-23. PubMed ID: 21049301 [TBL] [Abstract][Full Text] [Related]
2. Enzymatic activation of a matrix metalloproteinase inhibitor. Major Jourden JL; Cohen SM Chem Commun (Camb); 2010 Feb; 46(8):1241-3. PubMed ID: 20449263 [TBL] [Abstract][Full Text] [Related]
3. Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species. Deem TL; Cook-Mills JM Blood; 2004 Oct; 104(8):2385-93. PubMed ID: 15265790 [TBL] [Abstract][Full Text] [Related]
4. Investigation of self-immolative linkers in the design of hydrogen peroxide activated metalloprotein inhibitors. Jourden JL; Daniel KB; Cohen SM Chem Commun (Camb); 2011 Jul; 47(28):7968-70. PubMed ID: 21677985 [TBL] [Abstract][Full Text] [Related]
5. Carbamoylphosphonate-based matrix metalloproteinase inhibitor metal complexes: solution studies and stability constants. Towards a zinc-selective binding group. Farkas E; Katz Y; Bhusare S; Reich R; Röschenthaler GV; Königsmann M; Breuer E J Biol Inorg Chem; 2004 Apr; 9(3):307-15. PubMed ID: 14762707 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship. Yan YL; Miller MT; Cao Y; Cohen SM Bioorg Med Chem Lett; 2009 Apr; 19(7):1970-6. PubMed ID: 19261472 [TBL] [Abstract][Full Text] [Related]
7. Hydrogen peroxide activated matrix metalloproteinase inhibitors: a prodrug approach. Major Jourden JL; Cohen SM Angew Chem Int Ed Engl; 2010 Sep; 49(38):6795-7. PubMed ID: 20715043 [No Abstract] [Full Text] [Related]
8. Investigating chelating sulfonamides and their use in metalloproteinase inhibitors. Tanakit A; Rouffet M; Martin DP; Cohen SM Dalton Trans; 2012 Jun; 41(21):6507-15. PubMed ID: 22411188 [TBL] [Abstract][Full Text] [Related]
9. Zinc-binding groups modulate selective inhibition of MMPs. Agrawal A; Romero-Perez D; Jacobsen JA; Villarreal FJ; Cohen SM ChemMedChem; 2008 May; 3(5):812-20. PubMed ID: 18181119 [TBL] [Abstract][Full Text] [Related]
10. The balance between MMP-2/-9 and TIMP-1/-2 is shifted towards MMP in renal cell carcinomas and can be further disturbed by hydrogen peroxide. Hemmerlein B; Johanns U; Halbfass J; Böttcher T; Heuser M; Radzun HJ; Thelen P Int J Oncol; 2004 May; 24(5):1069-76. PubMed ID: 15067327 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of matrix metalloproteinase-1 induced by oxidative stress in human keratinocytes by mangiferin isolated from Anemarrhena asphodeloides. Chae S; Piao MJ; Kang KA; Zhang R; Kim KC; Youn UJ; Nam KW; Lee JH; Hyun JW Biosci Biotechnol Biochem; 2011; 75(12):2321-5. PubMed ID: 22146720 [TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes. Scozzafava A; Supuran CT J Med Chem; 2000 Oct; 43(20):3677-87. PubMed ID: 11020282 [TBL] [Abstract][Full Text] [Related]
13. Role of sulfonamide group in matrix metalloproteinase inhibitors. Cheng XC; Wang Q; Fang H; Xu WF Curr Med Chem; 2008; 15(4):368-73. PubMed ID: 18288991 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of Reactive Oxygen Species Sensitive Prodrugs of a NAMPT Inhibitor FK866. Xu Z; Wang H; Liu H; Chen H; Jiang B Molecules; 2022 Dec; 28(1):. PubMed ID: 36615364 [TBL] [Abstract][Full Text] [Related]
15. Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells. Zhou G; Peng F; Zhong Y; Chen Y; Tang M; Li D Int J Oncol; 2017 Mar; 50(3):933-941. PubMed ID: 28098862 [TBL] [Abstract][Full Text] [Related]
16. X-ray absorption studies of human matrix metalloproteinase-2 (MMP-2) bound to a highly selective mechanism-based inhibitor. comparison with the latent and active forms of the enzyme. Kleifeld O; Kotra LP; Gervasi DC; Brown S; Bernardo MM; Fridman R; Mobashery S; Sagi I J Biol Chem; 2001 May; 276(20):17125-31. PubMed ID: 11278946 [TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3beta is activated by matrix metalloproteinase-2 mediated proteolysis in cardiomyoblasts. Kandasamy AD; Schulz R Cardiovasc Res; 2009 Sep; 83(4):698-706. PubMed ID: 19493954 [TBL] [Abstract][Full Text] [Related]
18. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Jo Y; Yeon J; Kim HJ; Lee ST Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509 [TBL] [Abstract][Full Text] [Related]
19. Lipoteichoic acid isolated from Lactobacillus plantarum down-regulates UV-induced MMP-1 expression and up-regulates type I procollagen through the inhibition of reactive oxygen species generation. Hong YF; Lee Hy; Jung BJ; Jang S; Chung DK; Kim H Mol Immunol; 2015 Oct; 67(2 Pt B):248-55. PubMed ID: 26059754 [TBL] [Abstract][Full Text] [Related]